GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioVaxys Technology Corp (STU:5LB) » Definitions » Loans Receivable

BioVaxys Technology (STU:5LB) Loans Receivable : €0.12 Mil (As of Jul. 2023)


View and export this data going back to 2020. Start your Free Trial

What is BioVaxys Technology Loans Receivable?

BioVaxys Technology's Loans Receivable for the quarter that ended in Jul. 2023 was €0.12 Mil.

BioVaxys Technology's quarterly Loans Receivable increased from Jan. 2023 (€0.11 Mil) to Apr. 2023 (€0.12 Mil) but then stayed the same from Apr. 2023 (€0.12 Mil) to Jul. 2023 (€0.12 Mil).

BioVaxys Technology's annual Loans Receivable increased from Oct. 2020 (€0.00 Mil) to Oct. 2021 (€0.06 Mil) and increased from Oct. 2021 (€0.06 Mil) to Oct. 2022 (€0.12 Mil).


BioVaxys Technology Loans Receivable Historical Data

The historical data trend for BioVaxys Technology's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioVaxys Technology Loans Receivable Chart

BioVaxys Technology Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Oct22
Loans Receivable
- - - 0.06 0.12

BioVaxys Technology Quarterly Data
Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.12 0.11 0.12 0.12

BioVaxys Technology Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


BioVaxys Technology Loans Receivable Related Terms

Thank you for viewing the detailed overview of BioVaxys Technology's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


BioVaxys Technology (STU:5LB) Business Description

Traded in Other Exchanges
Address
146 Thirtieth Street, Suite 100, Etobicoke, ON, CAN, M8W 3D4
BioVaxys Technology Corp is a clinical-stage biopharma company. The company develops antiviral and anticancer vaccine platforms to treat SARS-CoV-2 and other viral infections, as well as ovarian cancer and other solid tumor types.

BioVaxys Technology (STU:5LB) Headlines

No Headlines